Project Grant R01DK144089
- Federal Grant Award Summary The University of Pittsburgh received a $190,404 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective June 1, 2026 through February 28, 2031. The award funds the development and testing of a pharmacist-led population health management (PHM) program designed to optimize guideline-recommended medication therapy in chronic...
- Federal Grant Award Summary The University of Pittsburgh received a $812,862 Project Grant award dated June 12, 2026, from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to identify novel biomarkers for early detection of diabetic kidney disease (DKD) in Type 1 Diabetes (T1D). The research project, scheduled for completion by March 31, 2030, focuses on discovering and validating...
- Federal Project Grant Award Summary The University of Pittsburgh received a $151,069 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective August 1, 2025 through July 31, 2030. This research award funds investigator-initiated biomedical research aimed at advancing understanding of kidney disease mechanisms and improving prevention and treatment...
- Federal Project Grant Award Summary The University of Pittsburgh received a $769,882 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 16, 2026, through March 31, 2031. This five-year research initiative investigates the molecular and physiological effects of calcineurin inhibitors (CNIs) on WNK body biomolecular condensates, with...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Pittsburgh a Project Grant totaling $148,986.00 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective August 1, 2025, through July 31, 2030. This five-year research initiative investigates the role of BK gamma (BKγ) auxiliary subunits in regulating potassium secretion within the renal distal nephron, with particular...
- Federal Project Grant Award Summary The University of Pennsylvania received a $792,019 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 15, 2026, with a completion date of January 31, 2031. This award supports research aimed at phenotyping and predicting ultrafiltration intolerance to guide clinical transitions from continuous kidney...
- Federal Grant Award Summary The University of Pittsburgh received a $2.48 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 15, 2025, with a completion date of August 31, 2029. The award supports basic biomedical research investigating the molecular mechanisms underlying benign prostatic hyperplasia (BPH) and lower urinary tract...
- Federal Project Grant Award Summary The University of Kansas Medical Center Research Institute, Inc. received a $166,740 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective August 1, 2025, through July 31, 2030. This award funds basic biomedical research aimed at elucidating the mechanisms by which urinary phosphate contributes to chronic kidney...
- Federal Project Grant Award Summary The University of Pittsburgh received a $664,240 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective March 18, 2026, with completion targeted for January 31, 2031. This research initiative investigates the epigenetic regulation of hypothalamic energy homeostasis, focusing on how histone-modifying enzymes...
- Federal Grant Award Summary The University of Pennsylvania received a $197,220 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, with completion scheduled for June 30, 2027. The grant funds comparative effectiveness research examining how Renin-Angiotensin System Inhibitor (RASI) and non-RASI-based antihypertensive...
The University of Pittsburgh received a $753,479 Project Grant awarded June 24, 2026, by the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to evaluate the clinical and cost-effectiveness of an enhanced population health management (PHM) intervention for chronic kidney disease (CKD) care delivery. The award funds research and implementation of K-CARE (Kidney-Coordinated Health Management Partnership), an electronic health record-based, multifaceted intervention designed to optimize collaboration between primary care physicians and nephrologists in delivering evidence-based CKD management. The intervention leverages a learning health system approach and includes centralized, remotely delivered services comprising nephrology electronic consultations, pharmacist-led medication management, nurse-led patient education, and physician academic detailing. The program has been scaled to 101 primary care practices within the health system, serving approximately 24% rural-living patients. The study will evaluate the long-term effectiveness of the K-CARE intervention while addressing therapeutic inertia among primary care providers and unfamiliarity with current CKD guidelines through reinforced education and experiential case-based learning. Enhanced program components include a renal social worker to address medication affordability and social risk factors, along with expanded clinical capacity through renal dietitians and renal-palliative specialists. The project extends through March 31, 2030, and is expected to generate evidence supporting scalable, resource-efficient approaches to optimize population-level CKD care delivery across diverse healthcare settings.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $753.5k | 6/26/26 |